HIGHLIGHTS
- who: Javier Narbona and colleagues from the Department of Biochemistry and Molecular Biology, Faculty of Chemical Sciences, Complutense University, Madrid, Spain have published the research: A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin -Sarcin, in the Journal: Cancers 2023, x of 13/01/2023
- what: The authors designed two different variants of non-immunogenic immunotoxins (IMTXA33u03b1SDI and IMTXA33furu03b1SDI) on deimmunized variant of the The work described herein represents a step forward in the design of potential therapeutic immunotoxins based on a non-immunogenic variant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.